Hongzhao Li

Hongzhao Li

Auto-generated profile, based on publicly available information

Hongzhao Li

Affiliation National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, Canada

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2022 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
HLHongzhao Li
Hongzhao Li
ABAlexander J. Bello
Alexander J. Bello
GSGreg Smith
Greg Smith
DKDominic M. S. Kielich
Dominic M. S. Kielich
JSJames Eric Strong
James Eric Strong
BPBrad S. Pickering
Brad S. Pickering
CRISPR (clustered regularly interspaced short palindromic repeats), an ancient defense mechanism used by prokaryotes to cleave nucleic acids from invading viruses and plasmids, is currently being harnessed by researchers worldwide to develop new point-of-need diagnostics. In CRISPR diagnostics, a CRISPR RNA (crRNA) containing a “spacer” sequence that specifically complements with the target nucleic acid sequence guides the activation of a CRISPR effector protein (Cas13a, Cas12a or Cas12b), leading to collateral cleavage of RNA or DNA reporters and enormous signal amplification. CRISPR function can be disrupted by some types of sequence mismatches between the spacer and target, according to previous studies. This poses a potential challenge in the detection of variable targets such as RNA viruses with a high degree of sequence diversity, since mismatches can result from target variations. To cover viral diversity, we propose in this study that during crRNA synthesis mixed nucleotide types (degenerate sequences) can be introduced into the spacer sequence positions corresponding to viral sequence variations. We test this crRNA design strategy in the context of the Cas13a-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) technology for detection of Crimean–Congo hemorrhagic fever virus (CCHFV), a biosafety level 4 pathogen with wide geographic distribution and broad sequence variability. The degenerate-sequence CRISPR diagnostic proves functional, sensitive, specific and rapid. It detects within 30–40 minutes 1 copy/μl of viral RNA from CCHFV strains representing all clades, and from more recently identified strains with new mutations in the CRISPR target region. Also importantly, it shows no cross-reactivity with a variety of CCHFV-related viruses. This proof-of-concept study demonstrates that the degenerate sequence-based CRISPR diagnostic is a promising tool of choice for effective detection of highly variable viral pathogens.

1 November 2007 in Journal of Endourology
Verified
Journal Article
Closed access
BFBin Fu
Bin Fu
XZXu Zhang
Xu Zhang
BLBin Lang
Bin Lang
KXKai Xu
Kai Xu
JZJun Zhang
Jun Zhang
BWBaojun Wang
Baojun Wang
Purpose: To create an animal model for teaching laparoscopic dismembered pyeloplasty in which a realistic anatomic environment and the technical points of the procedure could be duplicated. Materials and Methods: Ten pigs underwent general anesthesia, and the ureter was dissected and spatulated. The small intestine near the renal hilum was trimmed to replace the enlarged renal pelvis, and the “ureteropelvic” anastomosis was performed according to the standard operation steps. A double-pigtail stent was placed in the ureter in antegrade fashion. This model was used by trainees during their year of fellowship in advanced laparoscopic urology. A mentor–trainee fellowship program was planned to guarantee the success of the operations and the quality of the anastomoses. The learning curve was analyzed in terms of the time necessary to perform the task. Results: This model reproduced the technical complexity of laparoscopic dismembered pyeloplasty. The total operating time declined from 135 ± 14.6 minutes (range 121–155 minutes) to 62 ± 5.2 minutes (range 56–70 minutes) after the trainees had performed 12 pyeloplasties. The time needed for intraoperative antegrade stenting declined from 35 ± 12 minutes to 8 ± 2 minutes. Six pyeloplasties could be performed in every pig with adequate substitutes for an enlarged renal pelvis. With this training, all participants were able to perform ureteropelvic anastomosis and intraoperative antegrade stenting skillfully. Conclusion: This model not only allows trainees to acquire the skills necessary for laparoscopic dismembered pyeloplasty but also provides more practices with the use of a suitable renal pelvic substitute.

15 January 2016 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
HLHongzhao Li
Hongzhao Li
XWXun Wu
Xun Wu
SHSen Hou
Sen Hou
MMMouhannad Malek
Mouhannad Malek
AKAnna Kielkowska
Anna Kielkowska
AMAaron J. Marshall
Aaron J. Marshall
Cell migration is controlled by PI3Ks, which generate lipid messengers phosphatidylinositol-3,4,5-trisphosphate and phosphatidylinositol-3,4-bisphosphate [PI(3,4)P2] and consequently recruit pleckstrin homology (PH) domain–containing signaling proteins. PI3K inhibition impairs migration of normal and transformed B cells, an effect thought to partly underlie the therapeutic efficacy of PI3K inhibitors in treatment of B cell malignancies such as chronic lymphocytic leukemia. Although a number of studies have implicated phosphatidylinositol-3,4,5-trisphosphate in cell migration, it remains unknown whether PI(3,4)P2 plays a distinct role. Using the PI(3,4)P2-specific phosphatase inositol polyphosphate 4-phosphatase, we investigate the impact of depleting PI(3,4)P2 on migration behavior of malignant B cells. We find that cells expressing wild-type, but not phosphatase dead, inositol polyphosphate 4-phosphatase show impaired SDF-induced PI(3,4)P2 responses and reduced migration in Transwell chamber assays. Moreover, PI(3,4)P2 depletion in primary chronic lymphocytic leukemia cells significantly impaired their migration capacity. PI(3,4)P2 depletion reduced both overall motility and migration directionality in the presence of a stable chemokine gradient. Within chemotaxing B cells, the PI(3,4)P2-binding cytoskeletal regulator lamellipodin (Lpd) was found to colocalize with PI(3,4)P2 on the plasma membrane via its PH domain. Overexpression and knockdown studies indicated that Lpd levels significantly impact migration capacity. Moreover, the ability of Lpd to promote directional migration of B cells in an SDF-1 gradient was dependent on its PI(3,4)P2-binding PH domain. These results demonstrate that PI(3,4)P2 plays a significant role in cell migration via binding to specific cytoskeletal regulators such as Lpd, and they suggest that impairment of PI(3,4)P2-dependent processes may contribute to the therapeutic efficacy of PI3K inhibitors in B cell malignancies.

8 December 2021 in Frontiers in Oncology
Verified
Journal Article
Open access
ZLZheng Lv
Zheng Lv
HFHua-Yi Feng
Hua-Yi Feng
TWTao Wang
Tao Wang
HLHong-Zhao Li
Hong-Zhao Li
XZXu Zhang
Xu Zhang
Backgrounds: CD146 is highly expressed in various malignant tumors and associated with the poor prognosis. However, the role of CD146 in clear cell renal cell carcinoma (ccRCC) is still unknown. This study aimed to identify the role of CD146 in ccRCC by integrated bioinformatics analysis. Methods: CD146 mRNA expression and methylation data in ccRCC was examined using the TIMER, UALCAN, and MethSurv databases. CD146 expression in paraffin-embedded tissues (140 cancer samples and 140 paracancer tissues) from our cohort were examined by immunohistochemistry assay. The LinkedOmics database was used to study the signaling pathways related to CD146 expression. TIMER and TISIDB were used to analyze the correlations among CD146, CD146-coexpressed genes, tumor-infiltrating immune cells, and immunomodulators. The relationship between CD146 and drug response in renal cancer cell lines was analyzed by the CTRP and CCLE databases. Results: The mRNA and protein levels of CD146 were elevated in ccRCC tissues than that in paracancer tissues. The DNA methylation of CD146 in ccRCC tissues were lower than that in normal tissues. Importantly, high CD146 expression was associated with poor prognosis in patients with ccRCC. Furthermore, multivariate Cox regression analysis showed that CD146 was an independent prognostic factor in ccRCC. GO and KEGG pathway analyses indicated the co-expressed genes of CD146 were mainly related to a variety of immune-related pathways, including Th1 and Th2 cell differentiation, Th17 cell differentiation, and leukocyte transendothelial migration. Our data demonstrated that the expression and methylation status of CD146 were strongly correlated with immune infiltration levels, immunomodulators, and chemokines. Further, the sensitivity and resistance of renal cancer cell lines to some drugs were related to CD146 expression. Conclusions: Our study highlights the clinical significance of CD146 in ccRCC and provides novel insights into the immune function of CD146 in the tumor microenvironment.

18 February 2016 in Scientific Reports
Verified
Journal Article
Open access
LCLuyao Chen
Luyao Chen
HLHongzhao Li
Hongzhao Li
LGLiangyou Gu
Liangyou Gu
XMXin Ma
Xin Ma
XLXintao Li
Xintao Li
XZXu Zhang
Xu Zhang
The relationship between urinary collecting system invasion (UCSI) and oncological outcomes in renal cell carcinoma (RCC) patients has attracted extensive attention recent years. However, the reports were inconsistent and remain controversial. Thus, we performed a systematic literature search of PubMed, Embase, Web of Science and The Cochrane Library databases to identify relevant studies up to June 2015 and conducted a standard meta-analysis of survival outcomes. 17 studies containing 9012 RCC patients satisfied the inclusion criteria. Pooled HRs for overall survival (OS) and recurrence-free survival (RFS) were 1.45 (95% CI, 1.26–1.66, P < 0.001) and 2.27 (95% CI, 1.54–3.34, P < 0.001), respectively. Further subgroup analysis suggested that UCSI was significant associated with poor cancer-specific survival (CSS) in stage T1–T2 RCC (HR = 2.05, 95% CI: 1.43–2.96, P < 0.001) but not in stage T3–T4 tumors (HR = 1.08, 95% CI: 0.63–1.85, P = 0.771). Current evidence revealed that UCSI has a significant negative impact on OS and RFS in RCC patients and could be used to predict CSS especially in localized RCC. Thus, RCC patients with UCSI should be paid more attention by clinician and pathologist and require close follow up for their poor prognosis.

4 August 2014 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
SLSandrine T. Lafarge
Sandrine T. Lafarge
HLHongzhao Li
Hongzhao Li
SPSamantha D. Pauls
Samantha D. Pauls
SHSen Hou
Sen Hou
JJJames Johnston
James Johnston
AMAaron J. Marshall
Aaron J. Marshall